Trial intelligence / Profile preview

Pharmacokinetics of Continuous Remimazolam Infusion in Mechanically Ventilated ICU Patients

jRCTs041200076Recruiting

Start
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of remimazolam in None. Primary endpoint: Pharmacokinetics of Remimazolam. Started Jan 2021; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on jRCTs041200076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs041200076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call